Semaglo 3 mg (Tablet)
Unit Price: ৳ 455.00 (1 x 10: ৳ 4,550.00)
Strip Price: ৳ 4,550.00
Medicine Details
Category | Details |
---|---|
Generic | Semaglutide |
Company | Ziska pharmaceuticals ltd |
Also available as |
Product Title
- Semaglo Medication
Categories
- Diabetes Medication
- Weight Management Aid
Description
- Semaglo is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
- It is also used to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease
- For obesity, it is used as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients.
Color Options
- White
Dimensions
- Tablet: Various Sizes
- Injection: Various Sizes
Functions
- Reduces blood glucose in a glucose-dependent manner
- Stimulates insulin secretion
- Lowers glucagon secretion when blood glucose is high
- Reduces body weight and body fat mass by reducing appetite
Dosage Forms
- Tablet
- Injection
Dosage Instructions
- Take tablet at least 30 minutes before the first meal of the day with water
- Start with a low dose and increase gradually for better glycemic control
- Injection to be administered subcutaneously in the abdomen, thigh, or upper arm once weekly
Usage Method
- Oral
- Subcutaneous Injection
Material
- Semaglutide
Technical Specifications
- GLP-1 analogue with 94% sequence similar to human GLP-1
Design Elements
- Simple packaging
- Easy-to-read product information
Usability Features
- Weekly dosing for convenience
- Multiple dosing options for individual needs
Interaction Info
- Has the potential to impact the rate of absorption of concomitantly administered oral medicinal products
Contraindications
- Hypersensitivity to active substance or excipients
Side Effects
- Gastrointestinal disorders
- Nausea
- Diarrhea
- Vomiting
- Abdominal pain
- Constipation
- Allergic reactions
- Injection site reactions
- Pruritus
- Rash
Pregnancy Lactation Info
- Not to be used during pregnancy or breastfeeding
Precautions Warnings
- Not suitable for type 1 diabetes or diabetic ketoacidosis
- Monitor patients with diabetic retinopathy
Special Populations Info
- Not established for pediatric population below 18 years
- No dose adjustment required based on age or renal impairment
- Not recommended in end-stage renal disease
Overdose Effects
- Reported adverse reactions include nausea
- No specific antidote for overdose
- Appropriate supportive treatment to be initiated in case of overdose
Therapeutic Class
- GLP-1 Receptor Agonists
Storage Conditions
- Store in a refrigerator at 2-8°C
- Do not freeze
- Keep out of reach of children
Related Brands
- Potenza 1.34 mg/ml (SC Injection) - aci-limited
- Semaglo 0.5 mg/0.375 ml (SC Injection) - ziska-pharmaceuticals-ltd
- Semaglo 0.25 mg/0.188 ml (SC Injection) - ziska-pharmaceuticals-ltd
- Ozempic 1.34 mg/ml (SC Injection) - novo-nordisk-pharma-pvt-ltd
- Fitaro 0.5 mg/0.5 ml (SC Injection) - incepta-pharmaceuticals-ltd